Free Trial

NeuroSense Therapeutics (NRSN) News Today

NeuroSense Therapeutics logo
$0.95 -0.04 (-4.05%)
(As of 02:30 PM ET)
NeuroSense Therapeutics Secures Continued Nasdaq Listing
NeuroSense Completes Key ALS Trial Phase
Neurosense Therapeutics Secures $30 Million Equity Deal
NeuroSense Therapeutics Advances ALS Drug Development Plans
NeuroSense’s PrimeC shows microRNA improvement in ALS
NeuroSense’s PrimeC Shows Potential in ALS Treatment
NeuroSense Reports Patent Grant For PrimeC Formulation - Quick Facts
NeuroSense Therapeutics Ltd NRSN
Get NeuroSense Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NRSN and its competitors with MarketBeat's FREE daily newsletter.

Download Our Tesla Ebook For Free (Ad)

Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.

To claim your copy free of charge simply follow this link.

NRSN Media Mentions By Week

NRSN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NRSN
News Sentiment

0.64

0.47

Average
Medical
News Sentiment

NRSN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NRSN Articles
This Week

1

1

NRSN Articles
Average Week

Get NeuroSense Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NRSN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:NRSN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners